Insider Selling: GTx, Inc. (GTXI) VP Sells 4,965 Shares of Stock

GTx, Inc. (NASDAQ:GTXI) VP Henry Patton Doggrell sold 4,965 shares of the firm’s stock in a transaction on Friday, January 5th. The shares were sold at an average price of $11.33, for a total transaction of $56,253.45. Following the sale, the vice president now owns 54,804 shares in the company, valued at $620,929.32. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

GTx, Inc. (NASDAQ:GTXI) opened at $12.16 on Wednesday. The company has a market cap of $254.41, a price-to-earnings ratio of -6.91 and a beta of 1.77. GTx, Inc. has a 52 week low of $2.73 and a 52 week high of $13.35.

GTX (NASDAQ:GTXI) last released its earnings results on Tuesday, November 14th. The biopharmaceutical company reported ($0.53) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.28) by ($0.25). analysts anticipate that GTx, Inc. will post -1.61 EPS for the current year.

A number of brokerages have commented on GTXI. Zacks Investment Research cut shares of GTX from a “hold” rating to a “sell” rating in a research note on Wednesday, January 10th. Stifel Nicolaus began coverage on shares of GTX in a research note on Thursday, November 9th. They issued a “buy” rating for the company. Finally, Robert W. Baird began coverage on shares of GTX in a research note on Tuesday, November 21st. They issued an “outperform” rating and a $17.00 price objective for the company.

Several institutional investors have recently added to or reduced their stakes in GTXI. Bank of New York Mellon Corp bought a new stake in shares of GTX in the 2nd quarter worth about $124,000. Abingworth LLP bought a new stake in shares of GTX in the 3rd quarter worth about $2,781,000. Finally, Caxton Corp bought a new stake in shares of GTX in the 3rd quarter worth about $531,000. Hedge funds and other institutional investors own 11.57% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Insider Selling: GTx, Inc. (GTXI) VP Sells 4,965 Shares of Stock” was originally posted by BBNS and is the property of of BBNS. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://baseballnewssource.com/markets/gtx-inc-gtxi-vp-henry-patton-doggrell-sells-4965-shares-of-stock/1822654.html.

GTX Company Profile

GTx, Inc is a biopharmaceutical company focused on the discovery, development and commercialization of small molecules for the treatment of cancer, including treatments for breast and prostate cancer, and other medical conditions. The Company is engaged in the development of selective androgen receptor modulators (SARMs).

Receive News & Ratings for GTX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GTX and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires


Leave a Reply

 
© 2006-2018 BBNS.